Anti-Ntrk2 antibody

Cat.#: 176595

Size:

Special Price 241.9 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-Ntrk2 antibody
  • Documents
  • Description
    Rabbit monoclonal antibody to Ntrk2
  • Tested applications
    WB
  • Species reactivity
    Mouse, Rat
  • Alternative names
    Tkr antibody; trk antibody; Tkrb antibody; trkB antibody; trk-B antibody; GP145-TrkB/GP95-TrkB antibody
  • Isotype
    Rabbit IgG
  • Preparation
    This antigen of this antibody was recombinant protein within human trkb aa 100-450.
  • Clonality
    Monoclonal
  • Formulation
    Liquid, 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
  • Storage instructions
    Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
  • Applications

    WB: 1:500-1:2,000

  • Validations

    Fig1:; Western blot analysis of TrkB on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody ( 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature.; Positive control:; Lane 1: mouse brain tissue lysate; Lane 2: mouse cerebellum tissue lysate; Lane 3: rat cerebellum tissue lysate

    Fig1:; Western blot analysis of TrkB on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody ( 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature.; Positive control:; Lane 1: mouse brain tissue lysate; Lane 2: mouse cerebellum tissue lysate; Lane 3: rat cerebellum tissue lysate

  • Background
  • References
    • Wang X. et. al. A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma. PeerJ. 2019 Jun
    • Cocco E. et. al. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018 Dec

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"